bml 190 has been researched along with piperidines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
New, DC; Wong, YH | 1 |
Bissonnette, CJ; Klegeris, A; McGeer, PL | 1 |
2 other study(ies) available for bml 190 and piperidines
Article | Year |
---|---|
BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates.
Topics: Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Humans; Indomethacin; Inositol Phosphates; Ligands; Morpholines; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Second Messenger Systems | 2003 |
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Topics: Astrocytes; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Cytokines; Dronabinol; Formazans; Gene Expression; Humans; Indoles; Indomethacin; L-Lactate Dehydrogenase; Ligands; Microglia; Monocytes; Morpholines; Nerve Degeneration; Neurotoxicity Syndromes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Temporal Lobe; Tetrazolium Salts | 2003 |